AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for ALS – Video

Posted: May 12, 2013 at 10:44 pm




AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for ALS
Ole Isacson, Ph.D., McLean Hospital. Dr. Isacson is a CDMRP-funded investigator supported by the DoD Amyotrophic Lateral Sclerosis Research Program (ALSRP).

By: CDMRP

See the original post here:
AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for ALS - Video

Related Posts

Comments are closed.

Archives